Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

AIDS Research and Human Retroviruses

Volumn 17, Issue 16, 2001, Pages 1467-1471

  Martin Carbonero L ^a   Soriano, V ^a   Valencia, E ^a   Garcia Samaniego J ^a   Lopez M ^a   Gonzalez Lahoz J ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; HEPATITIS B VACCINE; INDINAVIR; INTERFERON; KETOCONAZOLE; NEVIRAPINE; RIBAVIRIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; CHRONIC DISEASE; FEMALE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE;

EID: 0035200295     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220152644160     Document Type: Article

References (23)

1. Declining morbidity and mortality among patients with advanced HIV infection
2. Changing patterns of mortality across Europe in patients infected with HIV-1
3. The epidemiology of hepatitis C in the west
4. Correlates of hepatitis C virus infections among drug users
5. Hepatitis C in the EuroSIDA cohort of European HIV-infected patients: Prevalence and prognostic value
6. Hepatitis C virus infection in patients infected with the human immunodeficiency virus
7. HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
8. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
9. Impact on chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
10. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
11. Mortality for liver disease in patients with HIV infection: A cohort study
12. Increasing mortality due to end-stage liver disease in patients with HIV infection
13. Hepatitis C virus infection as an opportunistic disease in persons infected with the human immunodeficiency virus
14. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
15. Hepatotoxicity after introduction of highly active antiretroviral therapy
16. Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C or B virus infection
17. Overall trends in CD4 counts and plasma viremia in a clinical setting since the introduction of highly active antiretroviral therapies
18. National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C
19. Consensus statement: EASL International Consensus Conference on hepatitis C
20. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus
21. Peginterferon alfa-2a in patients with chronic hepatitis C
22. Pegylated interferon alfa-2a (Pegasys) and ribavirin combination therapy for chronic hepatitis C: A phase II open-label study
23. Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients